Brian Rosenberger

Insider Reports History

Entity
Individual
Location
C/O Zynerba Pharmaceuticals, Inc., 80 West Lancaster Avenue, Suite 300, Devon, PA
Signature
/s/ Albert P. Parker, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brian Rosenberger:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Zynerba Pharmaceuticals, Inc. VP, Commercial & Business Dev. Common Stock 0 $1.33 Oct 10, 2023 Direct
Zynerba Pharmaceuticals, Inc. VP, Commercial & Business Dev. Stock Option (Right to Buy) 0 Oct 10, 2023 Direct

Insider Reports Filed by Brian Rosenberger

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ZYNE Zynerba Pharmaceuticals, Inc. Oct 10, 2023 4 $0 4 Oct 11, 2023 VP, Commercial & Business Dev.
ZYNE Zynerba Pharmaceuticals, Inc. Sep 12, 2023 2 -$8.5K 4 Sep 14, 2023 VP, Commercial & Business Dev.
ZYNE Zynerba Pharmaceuticals, Inc. Feb 7, 2023 2 -$3.07K 4 Feb 9, 2023 VP, Commercial & Business Dev.
ZYNE Zynerba Pharmaceuticals, Inc. Jan 31, 2023 2 -$2.86K 4 Feb 2, 2023 VP, Commercial & Business Dev.
ZYNE Zynerba Pharmaceuticals, Inc. Jan 23, 2023 2 -$7.57K 4 Jan 25, 2023 VP, Commercial & Business Dev.
ZYNE Zynerba Pharmaceuticals, Inc. Jul 18, 2022 2 -$4.72K 4 Jul 20, 2022 VP, Commercial & Business Dev.
ZYNE Zynerba Pharmaceuticals, Inc. Jan 26, 2022 2 $0 4 Jan 28, 2022 VP, Commercial & Business Dev.